Former Council of Economic Advisers acting chair Tomas Philipson addressed rising medicine prescription costs and the ongoing trade tensions with China. He emphasized that the delay in implementing tariffs could impact healthcare costs and the availability of pharmaceuticals in the U.S., highlighting the significant economic implications of these trade policies.